JO
XERS icon

John Overdeck’s Xeris Biopharma Holdings XERS Stock Holding History

John Overdeck’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Sell
1,885,503
-38,699
-2% -$247K 0.01% 1228
2026
Q1 		$11.2M Buy
1,924,202
+191,535
+11% +$1.27M 0.01% 1337
2025
Q4 		$13.6M Buy
1,732,667
+118,088
+7% +$929K 0.02% 936
2025
Q3 		$13.1M Buy
1,614,579
+399,880
+33% +$2.66M 0.02% 817
2025
Q2 		$5.67M Buy
1,214,699
+324,362
+36% +$1.49M 0.01% 1156
2025
Q1 		$4.89M Buy
+890,337
New +$3.59M 0.01% 1146
2024
Q3 		– Sell
-26,803
Closed -$60.3K – 3362
2024
Q2 		$60.3K Sell
26,803
-103,061
-79% -$208K ﹤0.01% 2871
2024
Q1 		$287K Buy
129,864
+32,515
+33% +$84.1K ﹤0.01% 2577
2023
Q4 		$229K Sell
97,349
-12,577
-11% -$23.2K ﹤0.01% 2781
2023
Q3 		$204K Sell
109,926
-92,286
-46% -$211K ﹤0.01% 2634
2023
Q2 		$530K Buy
+202,212
New +$515K ﹤0.01% 2303
2022
Q2 		– Sell
-150,109
Closed -$384K – 2985
2022
Q1 		$384K Buy
+150,109
New +$367K ﹤0.01% 2133
2021
Q1 		– Sell
-127,094
Closed -$625K – 4294
2020
Q4 		$625K Buy
+127,094
New +$636K ﹤0.01% 2341
2020
Q3 		– Sell
-119,071
Closed -$317K – 3627
2020
Q2 		$317K Sell
119,071
-59,579
-33% -$207K ﹤0.01% 2343
2020
Q1 		$348K Buy
178,650
+153,498
+610% +$660K ﹤0.01% 2192
2019
Q4 		$177K Buy
+25,152
New +$208K ﹤0.01% 3447
2019
Q2 		– Sell
-75,022
Closed -$753K – 3716
2019
Q1 		$753K Buy
+75,022
New +$961K ﹤0.01% 2000

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

John Overdeck's XERS Position: Q2 2026 in Review

John Overdeck reduced its Xeris Biopharma Holdings (XERS) stake by 2% in Q2 2026, selling an estimated $247K and leaving 1,885,503 shares worth $14.9M. The position accounts for 0.01% of the portfolio, ranked #1228.

John Overdeck first reported a position in XERS in Q1 2019 and has held it in 17 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • John Overdeck held 1,885,503 shares of Xeris Biopharma Holdings worth $14.9M as of Q2 2026.
  • John Overdeck sold 38,699 Xeris Biopharma Holdings shares in Q2 2026, an estimated $247K.
  • Xeris Biopharma Holdings made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1228 holding.
  • John Overdeck first reported a position in Xeris Biopharma Holdings in Q1 2019 and has held it in 17 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.